A Director at Misonix (NASDAQ: MSON) is Buying Shares

By Carrie Williams

Today, a Director at Misonix (NASDAQ: MSON), Thomas Patton, bought shares of MSON for $50.98K.

This is Patton’s first transaction since reporting a Buy transaction on CASM back in February 2015 In addition to Thomas Patton, 2 other MSON executives reported Buy trades in the last month.

Based on Misonix’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $8.32 million and GAAP net loss of $6.86 million. In comparison, last year the company earned revenue of $6.03 million and had a GAAP net loss of $614.8K. The company has a one-year high of $12 and a one-year low of $7.05. Currently, Misonix has an average volume of 1,000.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Misonix, Inc. is a medical device company that designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Its products include the bonescalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; the sonastar surgical aspirator, which is used to emulsify and remove soft and hard tumors; the sonicone wound cleansing and debridement system, which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The company’s ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.